Biotechnology Stocks I Performance Guide: Apellis Pharmaceuticals, Inc. (APLS)
APLS has no dividends.
Table and Chart of APLS Performance
See what a $1,000 investment in APLS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| APLS Returns | |
|---|---|
| Start Date | Dec-29-2017 |
| Start Price | $21.70 |
| End Date | May-08-2024 |
| End Price | $42.30 |
| # Prices | 78 |
| Min Date | Dec-31-2018 |
| Min Price | $13.19 |
| Max Date | Jun-30-2023 |
| Max Price | $91.10 |
| Total Return | 94.93% |
| Annualized Return | 10.81% |
| Current Value of $1,000 Purchase | $1,949 |
| Number Returns | 3,003 |
| Average Return | 80.73% |
| Number Profitable Returns | 2,443 |
| Percent Profitable Returns | 81.35% |
| Number Unprofitable Returns | 560 |
| Percent Unprofitable Returns | 18.65% |
| Profitable to Unprofitable Returns Ratio | 4.36 |
| APLS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $5,324,807,000 |
| Beta | 0.888 | Price to Sales | 15.75 |
| Earnings per Share | $-4.4500 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 32.1 |
| PRICE DATA | |
| 52 Week High | $94.75 |
| 52 Week Low | $19.83 |
| Analyst Target Price | $81.73 |
| 50-Day Moving Average | $55.51 |
| 200-Day Moving Average | $51.18 |
| FINANCIAL DATA | |
| Revenue per Share | $3.342 |
| Revenue | $396,591,000 |
| Profit Margin | -133.3% |
| Return on Equity | -290.1% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
APLS Compare Returns with S&P 500
APLS Trendline Chart
APLS Moving Average Chart
APLS Stock Return Map - See Patterns of Gains and Losses
APLS Stock Returns/Purchase Dates